Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Acta Diabetol. 2024 Jun;61(6):791-805. doi: 10.1007/s00592-024-02258-5. Epub 2024 Mar 14.
This study was undertaken to explicate the shared and distinctive genetic susceptibility and immune dysfunction in patients with T1D alone and T1D with CD (T1D + CD).
A total of 100 T1D, 50 T1D + CD and 150 healthy controls were recruited. HLA-DRB1/DQB1 alleles were determined by PCR-sequence-specific primer method, SNP genotyping for CTLA-4 and PTPN22 was done by simple probe-based SNP-array and genotyping for INS-23 Hph1 A/T was done by RFLP. Autoantibodies and cytokine estimation was done by ELISA. Immune-regulation was analysed by flow-cytometry. Clustering of autoantigen epitopes was done by epitope cluster analytical tool.
Both T1D alone and T1D + CD had a shared association of DRB103:01, DRB104, DRB301:07/15 and DQB102. DRB3*01:07/15 confers the highest risk for T1D with relative risk of 11.32 (5.74-22.31). Non-HLA gene polymorphisms PTPN22 and INS could discriminate between T1D and T1D + CD. T1D + CD have significantly higher titers of autoantibodies, expression of costimulatory molecules on CD4 and CD8 cells, and cytokine IL-17A and TGF-β1 levels compared to T1D patients. Epitopes from immunodominant regions of autoantigens of T1D and CD clustered together with 40% homology.
Same HLA genes provide susceptibility for both T1D and CD. Non-HLA genes CTLA4, PTPN22 and INS provide further susceptibility while different polymorphisms in PTPN22 and INS can discriminate between T1D and T1D + CD. Epitope homology between autoantigens of two diseases further encourages the two diseases to occur together. The T1D + CD being more common in females along with co-existence of thyroid autoimmunity, and have more immune dysregulated state than T1D alone.
本研究旨在阐明 T1D 患者与 T1D 合并 CD(T1D+CD)患者之间共同和独特的遗传易感性和免疫功能障碍。
共招募了 100 例 T1D 患者、50 例 T1D+CD 患者和 150 例健康对照者。采用 PCR-序列特异性引物法检测 HLA-DRB1/DQB1 等位基因,采用简单探针 SNP 芯片检测 CTLA-4 和 PTPN22 的 SNP 基因分型,采用 RFLP 检测 INS-23 Hph1 A/T 的基因分型。采用 ELISA 法检测自身抗体和细胞因子,采用流式细胞术分析免疫调节,采用表位簇分析工具分析表位簇。
T1D 患者与 T1D+CD 患者均存在 HLA-DRB103:01、DRB104、DRB301:07/15 和 DQB102 的共同关联。DRB3*01:07/15 赋予 T1D 最高风险,相对风险为 11.32(5.74-22.31)。非 HLA 基因多态性 PTPN22 和 INS 可区分 T1D 和 T1D+CD。与 T1D 患者相比,T1D+CD 患者的自身抗体滴度、CD4 和 CD8 细胞上共刺激分子的表达以及细胞因子 IL-17A 和 TGF-β1 水平显著升高。T1D 和 CD 的自身抗原免疫优势区的表位聚集在一起,具有 40%的同源性。
相同的 HLA 基因为 T1D 和 CD 提供易感性。非 HLA 基因 CTLA4、PTPN22 和 INS 提供进一步的易感性,而 PTPN22 和 INS 中的不同多态性可区分 T1D 和 T1D+CD。两种疾病自身抗原表位的同源性进一步鼓励两种疾病同时发生。T1D+CD 在女性中更为常见,同时伴有甲状腺自身免疫,并且比 T1D 单独存在时具有更多的免疫失调状态。